Genentech Dumps Another $650M in New Haven Biotech Arvinas Post author:Sam Post published:November 14, 2017 Post category:BioPharma Arvinas expanded an ongoing licensing deal with Genentech. Source: BioSpace You Might Also Like Viking Therapeutics Reports Fourth Quarter And Year-End 2016 Financial Results And Provides Corporate Update March 21, 2017 Roche's John Reed Is Stepping Down March 7, 2018 'Retired' Celgene Alum Lands Chairman Gig at Biotech Guru July 9, 2017
Viking Therapeutics Reports Fourth Quarter And Year-End 2016 Financial Results And Provides Corporate Update March 21, 2017
